Key facts
- This page summarizes Manuel Litchman MD's Form 4 filing for MUSTANG BIO, INC. (MBIO).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 07 Jul 2023, 16:06.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
Award
Additional SEC filing notes
Footnote F1
Represents an award of 5,000 restricted stock units that will vest in four annual installments after the grant date, vesting in full on April 24, 2027.
Footnote F2
Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.
Footnote F3
Includes restricted share units, which vest over various time periods.